CXI Healthcare Technology Group Balance Sheet Health
Financial Health criteria checks 6/6
CXI Healthcare Technology Group has a total shareholder equity of ₩483.0B and total debt of ₩178.7M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are ₩485.4B and ₩2.3B respectively. CXI Healthcare Technology Group's EBIT is ₩17.6B making its interest coverage ratio -66. It has cash and short-term investments of ₩178.4B.
Key information
0.04%
Debt to equity ratio
₩178.75m
Debt
Interest coverage ratio | -66x |
Cash | ₩178.42b |
Equity | ₩483.05b |
Total liabilities | ₩2.31b |
Total assets | ₩485.36b |
Recent financial health updates
No updates
Recent updates
CXI Healthcare Technology Group (KOSDAQ:900120) Is Posting Solid Earnings, But It Is Not All Good News
Dec 06Insufficient Growth At CXI Healthcare Technology Group Limited (KOSDAQ:900120) Hampers Share Price
Sep 30CXI Healthcare Technology Group (KOSDAQ:900120) Is Experiencing Growth In Returns On Capital
Aug 05Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S
May 30How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 02Financial Position Analysis
Short Term Liabilities: A900120's short term assets (₩196.9B) exceed its short term liabilities (₩2.0B).
Long Term Liabilities: A900120's short term assets (₩196.9B) exceed its long term liabilities (₩267.2M).
Debt to Equity History and Analysis
Debt Level: A900120 has more cash than its total debt.
Reducing Debt: A900120's debt to equity ratio has reduced from 0.4% to 0.04% over the past 5 years.
Debt Coverage: A900120's debt is well covered by operating cash flow (25370.9%).
Interest Coverage: A900120 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/22 20:00 |
End of Day Share Price | 2025/01/22 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CXI Healthcare Technology Group Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jong-Woo Kim | IBK Securities Co. Ltd. |
Sang-Hun Lee | iM Securities |
Doo Oh | LS Securities Co., Ltd. |